Evolving Strategies for BCLC-B Hepatocellular Carcinoma
Localized hepatocellular carcinoma patients in the BCLC-B stage may be better treated with liver resection instead of standard therapy.
Newsletter
HPB & Spleen
Every new paper in this field, in your inbox.
Merger of Two High-Volume Centers Lowers Pancreatic Surgery Risks
Combining two high-volume centers for pancreatoduodenectomies significantly improves patient outcomes.
Sequential Strategy Improves Survival in High-Risk Liver Metastases
A sequential approach combining neoadjuvant and adjuvant chemotherapy with surgery markedly boosts survival for high-risk colorectal liver metastasis patients.
Improved Survival After Liver Resection for HCC
Long-term survival rates for hepatocellular carcinoma patients significantly improved following liver resection over 20 years.
Duodenum-Preserving Resection is Safe and Effective
Duodenum-preserving pancreatic head resection shows promising outcomes for patients with benign and premalignant neoplasms.
New approaches in acute pancreatitis management
Early intervention and minimally invasive techniques are changing outcomes for acute pancreatitis.
Outcomes of Pancreatic Tumors Differ by Cancer Type
Surgeons need to know how outcomes differ between pancreatic neuroendocrine tumors (pnet) and ductal adenocarcinoma (pdac) after surgery.
Guidelines for Better Surgical Outcomes in Hepatocellular Carcinoma
Surgical resection outperforms other treatments for hepatocellular carcinoma in survival and recurrence rates, but patient selection is critical.
Rising burden of synchronous liver metastasis in cancer patients
Synchronous liver metastasis is on the rise, impacting surgical decisions and outcomes for various cancers.
New framework for post-total pancreatectomy hemorrhage
A proposed classification enhances understanding of bleeding complications after total pancreatectomy, impacting surgical management.